R. Kupwiwat

Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin–sulbactam combination therapy

Cameron Hurst, P. Higgins, Thammakorn Saethang, 2022, Scientific Reports.

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy

Cameron Hurst, A. Kicic, P. Ounjai, 2022, Scientific reports.

Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections

Cameron Hurst, P. Higgins, Thammakorn Saethang, 2021, Scientific Reports.

Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission

A. Nanbo, A. Kicic, P. Ounjai, 2024, iScience.

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial

A. Kicic, A. Reiersen, P. Ounjai, 2024, EClinicalMedicine.

Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiellapneumoniae infections

P. Monk, Cameron Hurst, S. Stick, 2023, iScience.